Jeremy Grantham’s GMO Goes Mainstream With ETF and Mega-Cap Bets

Published on December 16, 2024

Jeremy Grantham’s valuation-oriented investment firm is famous on Wall Street for trumpeting the contrarian, and decidedly bearish, views of its co-founder, seemingly every passing year.

Continue reading on website
Other news

The Fed Faces an Important Choice After This Rate Cut

December 16, 2024
There is widespread agreement in markets and among economists that the Federal Reserve will cut interest rates at its policy meeting on Wednesday.

Wall Street Eyes 2025 Volatility Spikes on Trump Tariffs, Geopolitics

December 16, 2024
Investors anticipating another calm year in 2025 should be on guard for more shocks like the one seen in August as uncertainty around Donald Trump’s tax and tariff policies threaten to roil markets.